We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-0.71%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$408M
AUM Growth
-$120M
Cap. Flow
-$111M
Cap. Flow %
-27.29%
Top 10 Hldgs %
85.04%
Holding
25
New
–
Increased
3
Reduced
5
Closed
7

Top Buys

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$18.3M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$3.27M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$3.27M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$37.1M
2
UNH icon
UnitedHealth
UNH
+$29.6M
3
NTRA icon
Natera
NTRA
+$13.3M
4
DXCM icon
DexCom
DXCM
+$13.1M
5
UTHR icon
United Therapeutics
UTHR
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1
Natera
NTRA
$46.4B
$53.8M 13.19%
339,764
-91,550
-21% -$13.3M
ARGX icon
2
argenx
ARGX
$54.2B
$46.1M 11.31%
74,990
– –
ILMN icon
3
Illumina
ILMN
$29B
$45.9M 11.25%
343,361
-43,993
-11% -$6.26M
ICLR icon
4
Icon
ICLR
$12.9B
$43.9M 10.75%
209,190
+78,400
+60% +$18.3M
INSM icon
5
Insmed
INSM
$29.5B
$35.5M 8.69%
513,700
– –
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$13.3B
$27.6M 6.76%
419,212
– –
RARE icon
7
Ultragenyx Pharmaceutical
RARE
$2.65B
$26.4M 6.47%
627,600
+65,900
+12% +$3.27M
INSP icon
8
Inspire Medical Systems
INSP
$1.73B
$25.3M 6.21%
136,603
– –
DXCM icon
9
DexCom
DXCM
$33.2B
$21.4M 5.23%
274,551
-176,941
-39% -$13.1M
NBIX icon
10
Neurocrine Biosciences
NBIX
$16.7B
$21.2M 5.19%
155,000
+26,400
+21% +$3.27M
PRCT icon
11
Procept Biorobotics
PRCT
$1.26B
$18.8M 4.6%
233,089
– –
ALNY icon
12
Alnylam Pharmaceuticals
ALNY
$29B
$17.9M 4.4%
76,256
– –
AGIO icon
13
Agios Pharmaceuticals
AGIO
$1.94B
$10.9M 2.67%
330,830
– –
UTHR icon
14
United Therapeutics
UTHR
$22.7B
$7.69M 1.89%
21,802
-32,297
-60% -$11.9M
ISRG icon
15
Intuitive Surgical
ISRG
$138B
$2.29M 0.56%
4,390
-3,000
-41% -$1.56M
IMCR icon
16
Immunocore
IMCR
$1.73B
$1.37M 0.33%
46,300
– –
TMDX icon
17
Transmedics
TMDX
$3.05B
$1.13M 0.28%
18,061
– –
GRAL
18
GRAIL Inc
GRAL
$3.29B
$948K 0.23%
53,124
– –
CRSP icon
19
PUT
CRISPR Therapeutics
CRSP
$5.17B
– –
-197,000
Closed -$9.26M
EXAS
20
DELISTED
Exact Sciences
EXAS
– –
-544,200
Closed -$37.1M
FDMT icon
21
4D Molecular Therapeutics
FDMT
$572M
– –
-462,911
Closed -$5M
HOWL icon
22
Werewolf Therapeutics
HOWL
$19M
– –
-700,000
Closed -$1.48M
LNTH icon
23
Lantheus
LNTH
$6.59B
– –
-43,200
Closed -$4.74M
UNH icon
24
UnitedHealth
UNH
$371B
– –
-50,700
Closed -$29.6M
VKTX icon
25
Viking Therapeutics
VKTX
$3.98B
– –
-45,000
Closed -$2.85M

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q4 2024 Portfolio in Review

As of Q4 2024, Eagle Health Investments held 25 positions worth $408M, down 23% from $528M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Eagle Health Investments withdrew a net $111M in Q4 2024, closing 7 positions and reducing 5 holdings. Its most notable exit was Exact Sciences, an estimated $37.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier.

Against the trend, Eagle Health Investments added an estimated $18.3M to Icon.

  • Eagle Health Investments added most to Icon in Q4 2024, an estimated $18.3M increase.
  • Eagle Health Investments's biggest Q4 2024 reduction was Natera, cutting an estimated $13.3M.
  • Eagle Health Investments fully exited Exact Sciences in Q4 2024, selling an estimated $37.1M.
  • Eagle Health Investments's ten largest holdings make up 85% of its $408M portfolio in Q4 2024.
  • Eagle Health Investments opened 0 new positions and closed 7 in Q4 2024.
  • Eagle Health Investments's portfolio value fell 23% quarter-over-quarter to $408M.

Based on Eagle Health Investments's 13F filing for Q4 2024, filed 12 Feb 2025.